Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
Rangel-Peláez C, Martínez-Gutiérrez L, Tristán-Manzano M, Callejas JL, Ortego-Centeno N, Martín F, Martín J. Rangel-Peláez C, et al. Among authors: tristan manzano m. Front Immunol. 2024 Dec 17;15:1502712. doi: 10.3389/fimmu.2024.1502712. eCollection 2024. Front Immunol. 2024. PMID: 39742256 Free PMC article. Review.
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.
Justicia-Lirio P, Tristán-Manzano M, Maldonado-Pérez N, Barbero-Jiménez C, Cortijo-Gutiérrez M, Pavlovic K, Molina-Estevez FJ, Muñoz P, Hinckley-Boned A, Rodriguez-Madoz JR, Prosper F, Griñán-Lison C, Navarro-Marchal SA, Panisello C, Muñoz-Ballester J, González-Sierra PA, Herrera C, Marchal JA, Martín F. Justicia-Lirio P, et al. Among authors: tristan manzano m. Mol Ther Nucleic Acids. 2024 Aug 15;35(4):102308. doi: 10.1016/j.omtn.2024.102308. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39640015 Free PMC article.
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome.
Pavlovic K, Carmona-Luque M, Corsi GI, Maldonado-Pérez N, Molina-Estevez FJ, Peralbo-Santaella E, Cortijo-Gutiérrez M, Justicia-Lirio P, Tristán-Manzano M, Ronco-Díaz V, Ballesteros-Ribelles A, Millán-López A, Heredia-Velázquez P, Fuster-García C, Cathomen T, Seemann SE, Gorodkin J, Martin F, Herrera C, Benabdellah K. Pavlovic K, et al. Among authors: tristan manzano m. Front Immunol. 2024 May 29;15:1401683. doi: 10.3389/fimmu.2024.1401683. eCollection 2024. Front Immunol. 2024. PMID: 38868778 Free PMC article.
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Cortijo-Gutierréz M, Tristán-Ramos P, Blanco-Benítez C, Pavlovic K, Aguilar-González A, Muñoz P, Molina-Estevez FJ, Griesche V, Marchal JA, Heras SR, Benabdellah K, Martin F. Tristán-Manzano M, et al. Mol Ther Nucleic Acids. 2023 Mar 28;32:322-339. doi: 10.1016/j.omtn.2023.03.018. eCollection 2023 Jun 13. Mol Ther Nucleic Acids. 2023. PMID: 37125150 Free PMC article.
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F. Maldonado-Pérez N, et al. Among authors: tristan manzano m. Front Immunol. 2022 Oct 6;13:1011858. doi: 10.3389/fimmu.2022.1011858. eCollection 2022. Front Immunol. 2022. PMID: 36275777 Free PMC article.
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Mol Ther Oncolytics. 2022 Jul 21;26:245. doi: 10.1016/j.omto.2022.07.005. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 35919458 Free PMC article.
Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Mol Ther Oncolytics. 2022 May 18;25:335-349. doi: 10.1016/j.omto.2022.05.003. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35694446 Free PMC article.
Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS2 Protein Docks.
Cortijo-Gutiérrez M, Sánchez-Hernández S, Tristán-Manzano M, Maldonado-Pérez N, Lopez-Onieva L, Real PJ, Herrera C, Marchal JA, Martin F, Benabdellah K. Cortijo-Gutiérrez M, et al. Among authors: tristan manzano m. Pharmaceutics. 2021 Aug 6;13(8):1217. doi: 10.3390/pharmaceutics13081217. Pharmaceutics. 2021. PMID: 34452178 Free PMC article.
Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells.
Navarro-Marchal SA, Griñán-Lisón C, Entrena JM, Ruiz-Alcalá G, Tristán-Manzano M, Martin F, Pérez-Victoria I, Peula-García JM, Marchal JA. Navarro-Marchal SA, et al. Among authors: tristan manzano m. Biomacromolecules. 2021 Apr 12;22(4):1374-1388. doi: 10.1021/acs.biomac.0c01546. Epub 2021 Mar 16. Biomacromolecules. 2021. PMID: 33724003
Using Gene Editing Approaches to Fine-Tune the Immune System.
Pavlovic K, Tristán-Manzano M, Maldonado-Pérez N, Cortijo-Gutierrez M, Sánchez-Hernández S, Justicia-Lirio P, Carmona MD, Herrera C, Martin F, Benabdellah K. Pavlovic K, et al. Among authors: tristan manzano m. Front Immunol. 2020 Sep 29;11:570672. doi: 10.3389/fimmu.2020.570672. eCollection 2020. Front Immunol. 2020. PMID: 33117361 Free PMC article. Review.
22 results